The expression levels of myeloid cell antigen CD13, T lymphocyte cell marker CD3, monocyte differentiation marker CD14, B lymphocyte differentiation marker CD20, and erythroid cell differentiation marker CD235a on the surface of DAC treated MDS-L cells were detected. Here, CD14 is linked to myelodysplastic syndrome.